Trials / Completed
CompletedNCT01162642
Green Tea Anticancer Mechanisms in Smokers
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 43 (actual)
- Sponsor
- Philip Diaz · Academic / Other
- Sex
- All
- Age
- 23 Years – 40 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to determine whether green tea may lower the risk of certain cancers.
Detailed description
Green tea contains phytochemicals, especially flavonoids. Phytochemicals are not absolutely required for normal functions, but may confer health benefits such as antioxidant actions. One can live without phytochemicals, but one may live longer and better with them. The phytochemicals in tea have been proposed to inhibit cancer onset via several different mechanisms. An obvious question is: Can anti-cancer actions of green tea be duplicated by black tea, which in the USA, is consumed more than green tea? The question remains unanswered, and will not be addressed by this project since many questions about green tea have not been answered yet. The contents of both type teas overlap in flavonoids, but green tea has more of the agents thought to be most effective. For example, some of the research cited below uses the flavonoid epigallocatechin gallate. Green tea has 5 times more of this flavonoid than black tea. This study has two purposes. First, a case will be made that green tea may have several anti-cancer mechanisms, but this contention is not well confirmed by human intervention studies. This case will be made by addressing four questions. Second, justification will be given for the choice of mechanisms to be examined in this project's human intervention.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | Green Tea | Green Tea 4 cups daily |
| OTHER | Placebo | 4 cups placebo tea for 6 weeks |
Timeline
- Start date
- 2010-06-01
- Primary completion
- 2013-08-01
- Completion
- 2013-08-01
- First posted
- 2010-07-14
- Last updated
- 2015-04-21
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT01162642. Inclusion in this directory is not an endorsement.